World ADC 2017
Events
… comprehensive 3 streamed programme covered every element of ADCs from discovery, development, manufacturing and … Mass Spectrometry for the Characterisation & Bioanalysis of ADCs by Arnaud Delobel, R&D Director, Quality Assistance … mapping approach with ETD fragmentation Bioanalysis of ADCs using immunoaffinity mass spectrometry The slides are …

Mass Spectrometry Toolkit for the characterisation of ADCs

Resources
… technologies can be implemented for the efficient study of ADCs using analyses optimised for each level of information … and optimised approaches for the characterisation of ADCs by mass spectrometry, based on different levels of … technologies can be implemented for the efficient study of ADCs using analyses optimised for each level of information …

8th World ADC Europe Summit 2018
Events
… streamed programme covered every element of ADCs from discovery, development, … Quality Assistance  adds value to your ADCs development. Thanks to our combined experience with … methods and key considerations to efficiently bring ADCs to the market. Poster presentation Venue: Maritim …

10th World ADC Europe Summit 2020
Events
… streamed programme covered every element of ADCs from discovery, development, … Quality Assistance  adds value to your ADCs development. Thanks to our combined experience with …

World ADC Europe Summit 2022
Events
… streamed programme covers every element of ADCs from discovery, development, … Quality Assistance  adds value to your ADCs development. Thanks to our combined experience with … methods as per ICH guidelines Characterisation of ADCs at intact, sub-unit and peptide levels Bioassays …

9th World ADC Europe Summit 2019
Events
… streamed programme covered every element of ADCs from discovery, development, … Quality Assistance  adds value to your ADCs development. Thanks to our combined experience with …

Development and use of 2D-LC/MS as a versatile and powerful tool for the analysis of mAbs and ADCs in a regulated environment

Resources
… monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) have emerged as potent and specific anticancer agents. … post-translational modifications, and – in the case of ADCs – range/average number of conjugated drugs … companies in the development and control of their mAbs and ADCs. … … Development and use of 2D-LC/MS as a versatile and …